Abridge vs Nabla

Nabla focuses on speed and simplicity: sub-10-second note processing, real-time dictation with speaker differentiation, auto-generated SOAP notes, and customizable templates. Its ambient AI removes non-medical conversation and supports multiple note types. Integration is limited to Epic and athenahealth, but it offers an API for custom connections. Abridge, leveraging GPT-5.5 (announced April 2026), provides a Contextual Reasoning Engine for higher accuracy, real-time clinical decision support, pre-visit summarization, and automated coding. It also offers nursing documentation, multi-language support (28 languages), and real-time prior authorization. Abridge's confabulation elimination science reduces errors, and its enterprise integrations span major health systems like Kaiser, Johns Hopkins, and Mayo Clinic. A recent news (May 2026) highlights scaling Abridge for nurses at the bedside with OpenAI models. While Nabla excels in speed, Abridge leads in depth of features, enterprise readiness, and AI capacity.

Nabla uses a paid subscription model with specific pricing tiers (undisclosed in data but referenced as 'paid'). It targets clinicians and mid-size organizations, likely with per-provider pricing. Abridge requires contacting sales, typical for enterprise deployments. Given Abridge's adoption by 300+ health systems (including Kaiser, Duke, Mayo), its pricing is likely higher but customized for large-scale use. Nabla may be more affordable for smaller practices, while Abridge's ROI is justified by its 86% documentation reduction and revenue cycle automation. Neither offers free tiers, but Nabla's transparency on pricing may appeal to budget-conscious buyers. Recent news (e.g., Adventist Health trust building, Geisinger scaling to 1,000+ clinicians) suggests Abridge's enterprise value is strong, but Nabla's growing adoption (190+ organizations) indicates competitive pricing for its target market.